Australian and New Zealand Intensive Care Research Centre clinical trials
Australian and New Zealand Intensive Care Research Centre is the lead sponsor of 17 current clinical trials in our Australia, Ireland, Germany, Belgium, Switzerland, India, Brazil, Japan and Canada registers. 9 are recruiting patients now. The most common phase is Phase 3. The drugs named most often in its trials are Aclasta, Denosumab and Epoetin Alfa. The most-studied condition is Extracorporeal Membrane Oxygenation Complication.
ClinicalTrials.gov trials by status
Trials by phase
Clinical trials sponsored by Australian and New Zealand Intensive Care Research Centre
17 on ClinicalTrials.gov| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
ErythroPOietin Alfa to Prevent Mortality and Reduce Severe Disability in Critically Ill TRAUMA Patients
NCT04588311 · Trauma, Traumatic Injury, Traumatic Brain Injury
Drug: Epoetin Alfa |
Phase 3 | Recruiting | 2020-11 | Ireland, Germany, Belgium, Switzerland, Australia |
|
Trial of Venovenous ECMO to De-Sedate, Extubate and Mobilise in Hypoxic Respiratory Failure
NCT05562505 · ClinicalTrials.gov ↗ · Mechanical Ventilation Complication, Hypoxemia, Acute Respiratory Distress Syndrome Due to COVID-19
|
Not applicable | Recruiting | 2022-11 | Germany, Australia |
|
The EXCEL Registry of Patients Requiring ECMO
NCT03793257 · ClinicalTrials.gov ↗ · Critically Ill, Acute Respiratory Failure, Acute Heart Failure
|
Observational | Recruiting | 2019-02 | Australia |
|
Bone Loss Prevention With Zoledronic Acid or Denosumab in Critically Ill Adults
NCT04608630 · ClinicalTrials.gov ↗ · Critical Illness, Osteoporosis
|
Phase 2 | Recruiting | 2021-07 | Australia |
|
Nutrition in Paediatric Critical Care
NCT06695078 · ClinicalTrials.gov ↗ · ICU, Nutrition, Paediatric
|
Observational | Recruiting | 2021-06 | Australia |
|
Nutrition Practice in Critically Ill Adults
NCT06576895 · ClinicalTrials.gov ↗ · Critical Illness
|
Observational | Recruiting | 2024-08 | Australia |
|
RECOMMEND Platform Trial
NCT06526533 · Extracorporeal Membrane Oxygenation Complication, ARDS (Acute Respiratory Distress Syndrome), Intensive Care Medicine
|
Phase 3 | Recruiting | 2026-03 | Australia |
|
Red Blood Cell Transfusion in ECMO - A Feasibility Trial
NCT05814094 · ClinicalTrials.gov ↗ · Blood Loss Anemia, Extracorporeal Membrane Oxygenation Complication, Disability Physical
|
Not applicable | Recruiting | 2023-09 | Australia |
|
Short Period Incidence Study of Severe Acute Respiratory Illness
NCT02498587 · ClinicalTrials.gov ↗ · Severe Acute Respiratory Infection
|
Observational | Recruiting | 2016-01 | Australia |
|
Improving Survivorship for Critically Ill Patients Aged 65 and Over
NCT07175961 · ClinicalTrials.gov ↗ · Critical Illness, Recovery Outcomes, Care Coordination
|
Phase 3 | Not yet open | 2025-11 | Australia |
|
The AminoECMO Pilot Trial
NCT07438262 · ClinicalTrials.gov ↗ · Acute Kidney Injury
|
Phase 2 | Not yet open | 2026-02 | Australia |
|
The TEAM Long-Term Cohort Study (A Sub-study of TEAM(III))
NCT05298982 · ClinicalTrials.gov ↗ · Critically Ill, Mechanical Ventilation, Long Term Outcome
|
Observational | By invitation | 2020-02 | Australia |
|
Australasian Resuscitation In Sepsis Evaluation: FLUid or Vasopressors In Emergency Department Sepsis
NCT04569942 · Shock, Septic
Drug: Vasopressor |
Phase 3 | Active, closed | 2021-10 | Ireland, Australia |
|
SODium BICarbonate for Metabolic Acidosis in the ICU
NCT05697770 · Metabolic Acidosis, Shock
Drug: Sodium Bicarbonate |
Phase 3 | Active, closed | 2023-04 | India, Brazil, Japan, Australia |
|
The Cryopreserved vs. Liquid Platelets Trial
NCT03991481 · ClinicalTrials.gov ↗ · Surgical Blood Loss, Hemorrhage
|
Phase 3 | Active, closed | 2021-08 | Australia |
|
The CPR, Pre-hospital ECPR and Early Reperfusion Study: A Target Trial Emulation
NCT07679737 · ClinicalTrials.gov ↗ · Out of Hospital Cardiac Arrest, Extracorporeal Cardiopulmonary Resuscitation
|
Observational | Active, closed | 2025-01 | Australia |
|
Early Rehabilitation in Patients on Extracorporeal Membrane Oxygenation
NCT05003609 · ClinicalTrials.gov ↗ · Extracorporeal Membrane Oxygenation Complication
|
Not applicable | Active, closed | 2022-04 | Canada, Australia |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
Drugs in Australian and New Zealand Intensive Care Research Centre trials
8 compoundsDrugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.
Conditions in Australian and New Zealand Intensive Care Research Centre trials
37 conditionsBy trial register
A trial with sites in more than one country appears in each of those registers.
Other sponsors in Extracorporeal Membrane Oxygenation Complication
| Sponsor | Trials |
|---|---|
| Xiaotong Hou | 2 |
| Xenios | 2 |
| Sydney Local Health District | 1 |
Sponsors with the most current trials registered for this condition.
Questions about Australian and New Zealand Intensive Care Research Centre trials
How many clinical trials does Australian and New Zealand Intensive Care Research Centre sponsor?
Australian and New Zealand Intensive Care Research Centre is the lead sponsor of 17 current trials on ClinicalTrials.gov in our Australia, Ireland, Germany, Belgium, Switzerland, India, Brazil, Japan and Canada registers, as of the registry sync on 10 November 2026. Completed and withdrawn studies are not counted.
Are Australian and New Zealand Intensive Care Research Centre trials recruiting?
Yes. 9 of its 17 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Which drugs is Australian and New Zealand Intensive Care Research Centre testing?
Its current trials name 8 drugs and biologicals as interventions. The most frequent are Aclasta (1), Denosumab (1), Epoetin Alfa (1), Prolia (1) and Sodium Bicarbonate (1). The number in brackets is how many of its trials name each drug.
Does Australian and New Zealand Intensive Care Research Centre have clinical trials in Ireland?
Yes. 2 trials in our Ireland register (ClinicalTrials.gov). Some may be the same study registered in both. See the Irish clinical trials register for sites and contacts.
Where does this information come from?
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
How this page is built
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
- EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 10 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.